Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
Luciferase | 7 | 0 | 0 | 7 |
glp-1 receptor, partial | 5 | 0 | 0 | 5 |
hypoxia-inducible factor 1 alpha subunit | 5 | 0 | 0 | 5 |
RAR-related orphan receptor gamma | 9 | 0 | 0 | 9 |
ATAD5 protein, partial | 5 | 0 | 0 | 5 |
Fumarate hydratase | 4 | 0 | 0 | 4 |
TDP1 protein | 12 | 0 | 0 | 12 |
GLI family zinc finger 3 | 12 | 0 | 0 | 12 |
AR protein | 15 | 0 | 0 | 15 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 10 | 0 | 0 | 10 |
progesterone receptor | 7 | 0 | 0 | 7 |
glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
retinoic acid nuclear receptor alpha variant 1 | 13 | 0 | 0 | 13 |
retinoid X nuclear receptor alpha | 7 | 0 | 0 | 7 |
estrogen-related nuclear receptor alpha | 14 | 0 | 0 | 14 |
farnesoid X nuclear receptor | 9 | 0 | 0 | 9 |
pregnane X nuclear receptor | 10 | 0 | 0 | 10 |
estrogen nuclear receptor alpha | 17 | 0 | 0 | 17 |
polyprotein | 4 | 0 | 0 | 4 |
67.9K protein | 4 | 0 | 0 | 4 |
peroxisome proliferator activated receptor gamma | 10 | 0 | 0 | 10 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
caspase-3 | 1 | 0 | 0 | 1 |
IDH1 | 5 | 0 | 0 | 5 |
euchromatic histone-lysine N-methyltransferase 2 | 16 | 0 | 0 | 16 |
aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 9 | 0 | 0 | 9 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 8 | 0 | 0 | 8 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Histone H2A.x | 7 | 0 | 0 | 7 |
cellular tumor antigen p53 isoform a | 5 | 0 | 0 | 5 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
chromobox protein homolog 1 | 9 | 0 | 0 | 9 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 11 | 0 | 0 | 11 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 5 | 0 | 0 | 5 |
mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
plasminogen precursor | 3 | 0 | 0 | 3 |
urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
geminin | 13 | 0 | 0 | 13 |
Vif | 0 | 0 | 0 | 1 |
peripheral myelin protein 22 | 7 | 0 | 0 | 7 |
survival motor neuron protein isoform d | 7 | 0 | 0 | 7 |
muscleblind-like protein 1 isoform 1 | 6 | 0 | 0 | 6 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 8 | 0 | 0 | 8 |
neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
ATP-binding cassette sub-family C member 3 | 0 | 9 | 0 | 9 |
Multidrug resistance-associated protein 4 | 0 | 9 | 0 | 9 |
Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
Bile salt export pump | 0 | 14 | 0 | 14 |
Interferon beta | 6 | 0 | 0 | 6 |
Cellular tumor antigen p53 | 13 | 0 | 0 | 13 |
Integrin beta-3 | 4 | 0 | 0 | 4 |
Integrin alpha-IIb | 4 | 0 | 0 | 4 |
Methionine aminopeptidase | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 6 | 0 | 0 | 6 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 9 | 0 | 9 |
ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
Ataxin-2 | 7 | 0 | 0 | 7 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 7 | 0 | 0 | 7 |
Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 6 | 0 | 0 | 6 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
Chain A, Cruzipain | 3 | 0 | 0 | 3 |
Beta-lactamase | 0 | 1 | 0 | 2 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
GLS protein | 5 | 0 | 0 | 5 |
apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase type 2 | 0 | 0 | 1 | 4 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
DNA polymerase beta | 3 | 0 | 0 | 3 |
DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 3 |
60 kDa heat shock protein, mitochondrial | 0 | 4 | 0 | 4 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 1 | 0 | 3 | 0 | 3 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Spike glycoprotein | 4 | 0 | 0 | 4 |
10 kDa heat shock protein, mitochondrial | 0 | 4 | 0 | 4 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
Thiosulfate sulfurtransferase | 0 | 4 | 0 | 4 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 4 |
Efflux transporter | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Class D beta-lactamase | 0 | 0 | 0 | 1 |
60 kDa chaperonin | 0 | 4 | 0 | 4 |
Metallo-beta-lactamase | 0 | 0 | 0 | 3 |
Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 1 | 4 |
10 kDa chaperonin | 0 | 4 | 0 | 4 |
Metallo-b-lactamase | 0 | 0 | 0 | 4 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 3 |
Histamine H3 receptor | 0 | 0 | 0 | 3 |
Beta-lactamase class B VIM-2 | 0 | 0 | 1 | 5 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 4 |
ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
interleukin 8 | 3 | 0 | 0 | 3 |
acetylcholinesterase | 6 | 0 | 0 | 6 |
thioredoxin reductase | 8 | 0 | 0 | 8 |
phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
Microtubule-associated protein tau | 8 | 0 | 0 | 8 |
thioredoxin glutathione reductase | 6 | 0 | 0 | 6 |
EWS/FLI fusion protein | 8 | 0 | 0 | 8 |
G | 4 | 0 | 0 | 4 |
P53 | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
arylsulfatase A | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
peripheral myelin protein 22 isoform 1 | 5 | 0 | 0 | 5 |
hemoglobin subunit beta | 4 | 0 | 0 | 4 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 12 | 0 | 0 | 12 |
cytochrome P450 3A4 isoform 1 | 4 | 0 | 0 | 4 |
M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 4 | 0 | 1 | 5 |
Bile salt export pump | 0 | 2 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 4 | 0 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit delta | 4 | 0 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 4 | 0 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 4 | 0 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 4 | 0 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 4 | 0 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 4 | 0 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 4 | 0 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 4 | 0 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 4 | 0 | 1 | 5 |
Nuclear receptor ROR-gamma | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 4 | 0 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit beta-3 | 4 | 0 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit beta-2 | 4 | 0 | 1 | 5 |
GABA theta subunit | 4 | 0 | 1 | 5 |
Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 4 | 0 | 1 | 5 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
DNA topoisomerase | 0 | 1 | 0 | 1 |
15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
Thrombopoietin | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 8 | 0 | 0 | 8 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
glucocerebrosidase | 2 | 0 | 0 | 2 |
putative alpha-glucosidase | 1 | 0 | 0 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
huntingtin isoform 2 | 2 | 0 | 0 | 2 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
eukaryotic translation initiation factor 2-alpha kinase 3 isoform 1 precursor | 0 | 0 | 1 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 4 | 0 | 0 | 4 |
Telomerase reverse transcriptase | 0 | 2 | 0 | 2 |
Serine/threonine-protein kinase Chk1 | 0 | 0 | 1 | 1 |
Histone deacetylase 3 | 0 | 1 | 0 | 1 |
Type-2 restriction enzyme ScaI | 0 | 1 | 0 | 1 |
Deoxyribonuclease-2-alpha | 0 | 1 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 2 | 0 | 1 | 0 | 1 |
Deoxyribonuclease-1 | 0 | 1 | 0 | 1 |
Type-2 restriction enzyme PstI | 0 | 1 | 0 | 1 |
Type-2 restriction enzyme EcoRI | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 1 | 2 | 4 |
DNA ligase | 0 | 1 | 0 | 1 |
Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
DNA topoisomerase 1 | 0 | 2 | 1 | 7 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 1 |
Type-2 restriction enzyme BamHI | 0 | 1 | 0 | 1 |
Somatostatin receptor type 1 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Type-2 restriction enzyme HindIII | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Histone deacetylase 4 | 0 | 1 | 0 | 1 |
Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
DNA topoisomerase 2-beta | 0 | 0 | 0 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 1 | 0 | 1 |
Histone deacetylase 2 | 0 | 1 | 0 | 1 |
DNA topoisomerase type IB small subunit | 0 | 0 | 1 | 1 |
Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
Histone deacetylase 11 | 0 | 1 | 0 | 1 |
Histone deacetylase 8 | 0 | 1 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Histone deacetylase 9 | 0 | 1 | 0 | 1 |
Histone deacetylase 5 | 0 | 1 | 0 | 1 |
flap endonuclease 1 | 3 | 0 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Arginase | 0 | 2 | 0 | 2 |
Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 1 | 1 | 0 | 2 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 0 | 0 | 2 |
Delta-type opioid receptor | 0 | 0 | 0 | 2 |
Kappa-type opioid receptor | 0 | 0 | 0 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Melatonin receptor type 1A | 0 | 0 | 1 | 1 |
Melatonin receptor type 1B | 0 | 0 | 1 | 1 |
Death-associated protein kinase 1 | 0 | 2 | 0 | 2 |
Beta-secretase 1 | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
USP1 protein, partial | 6 | 0 | 0 | 6 |
vitamin D3 receptor isoform VDRA | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
Vitamin D3 receptor | 0 | 1 | 1 | 5 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 3 |
Beta-lactamase TEM | 0 | 1 | 0 | 3 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 5 | 0 | 0 | 5 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Amyloid-beta precursor protein | 1 | 2 | 0 | 3 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 2 | 0 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | 0 | 1 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
Trypsin | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
Coagulation factor VII | 0 | 2 | 0 | 2 |
Aromatase | 0 | 3 | 0 | 3 |
Tissue factor | 0 | 2 | 0 | 2 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 3 | 3 |
Oxoeicosanoid receptor 1 | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Synaptojanin-2 | 0 | 1 | 0 | 1 |
Synaptojanin-1 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 4 |
Hepatocyte growth factor receptor | 0 | 3 | 0 | 3 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 2 | 0 | 2 |
Apoptosis regulator Bcl-2 | 0 | 3 | 0 | 3 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
Fatty acid synthase | 0 | 2 | 0 | 2 |
Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-5 | 0 | 2 | 0 | 2 |
Cannabinoid receptor 2 | 0 | 2 | 0 | 2 |
Alpha-synuclein | 0 | 2 | 0 | 2 |
DNA repair protein RAD52 homolog | 0 | 2 | 0 | 2 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 2 | 0 | 2 |
ELAV-like protein 3 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
Reverse transcriptase/RNaseH | 0 | 2 | 0 | 2 |
Enoyl-acyl-carrier protein reductase | 0 | 4 | 0 | 4 |
3-oxoacyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 3 |
Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 4 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 0 | 1 | 1 |
Chain A, POLYMERASE PA | 0 | 1 | 0 | 1 |
Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
galactokinase | 1 | 0 | 0 | 1 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
Polycomb protein EED | 0 | 0 | 1 | 1 |
NAD kinase | 0 | 2 | 1 | 3 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
Transthyretin | 0 | 0 | 1 | 2 |
Polymerase acidic protein | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
Heme oxygenase 1 | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
Matrilysin | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Alpha-amylase 1A | 0 | 1 | 0 | 1 |
Microtubule-associated protein tau | 0 | 1 | 0 | 1 |
CPG DNA methylase | 0 | 1 | 0 | 1 |
Lethal factor | 0 | 1 | 0 | 1 |
Phosphoglycerate mutase 1 | 0 | 1 | 0 | 1 |
Heme oxygenase 2 | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 0 | 1 | 1 |
DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Signal transducer and activator of transcription 1-alpha/beta | 0 | 0 | 1 | 1 |
Fatty acid synthase | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-14 | 0 | 1 | 0 | 1 |
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 1 | 0 | 1 |
Squalene monooxygenase | 0 | 1 | 0 | 1 |
BH3-interacting domain death agonist | 0 | 1 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 0 | 1 | 0 | 1 |
Lactoperoxidase | 0 | 0 | 0 | 1 |
Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 1 | 0 | 1 |
Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
Alpha-(1,3)-fucosyltransferase 7 | 0 | 1 | 0 | 1 |
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 1 | 0 | 1 |
Bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
3-oxoacyl-[acyl-carrier-protein] reductase | 0 | 1 | 0 | 1 |
MAP kinase-activated protein kinase 5 | 0 | 1 | 0 | 1 |
CREB-binding protein | 0 | 1 | 0 | 1 |
Histone acetyltransferase KAT2B | 0 | 1 | 0 | 1 |
Bcl-2-like protein 2 | 0 | 1 | 0 | 1 |
Bcl2-associated agonist of cell death | 0 | 1 | 0 | 1 |
Histone acetyltransferase KAT5 | 0 | 1 | 0 | 1 |
Bcl-2-like protein 10 | 0 | 1 | 0 | 1 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
pregnane X receptor | 2 | 0 | 0 | 2 |
estrogen receptor 2 (ER beta) | 5 | 0 | 0 | 5 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
Vpr | 1 | 0 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 1 | 1 | 2 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 2 |
Cytochrome P450 2C8 | 0 | 0 | 0 | 1 |
Mast/stem cell growth factor receptor Kit | 0 | 1 | 1 | 2 |
Breakpoint cluster region protein | 0 | 0 | 1 | 1 |
Platelet-derived growth factor receptor alpha | 0 | 1 | 1 | 2 |
Cytochrome P450 3A5 | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 2 |
BlaVIM-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 1 | 2 |
Caspase-1 | 0 | 1 | 0 | 1 |
Caspase-3 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 0 | 1 | 1 |
Cytochrome P450 2A6 | 0 | 1 | 1 | 2 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
Chain A, Adipocyte Lipid-binding Protein | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
putative potassium channel subunit | 0 | 0 | 1 | 1 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 0 | 1 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, adipocyte | 0 | 2 | 0 | 2 |
Protein kinase C alpha type | 0 | 0 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Fatty acid-binding protein 5 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor delta | 0 | 0 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 1 | 2 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Arylacetamide deacetylase | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 2 | 1 | 3 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Androgen receptor | 0 | 1 | 0 | 1 |
Thyroid hormone receptor alpha | 0 | 2 | 2 | 4 |
Thyroid hormone receptor beta | 0 | 2 | 2 | 4 |
Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
SLC16A10 protein | 0 | 0 | 0 | 1 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Tryprostatin B synthase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |